ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $273,000 | -14.4% | 39,503 | +9.7% | 0.01% | -14.3% |
| Q2 2015 | $319,000 | -3.3% | 36,013 | +7.6% | 0.01% | 0.0% |
| Q1 2015 | $330,000 | +43.5% | 33,469 | +78.0% | 0.01% | +40.0% |
| Q4 2014 | $230,000 | +109.1% | 18,800 | +71.2% | 0.01% | +150.0% |
| Q3 2014 | $110,000 | – | 10,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 5,191,600 | $8,255,000 | 4.47% |
| RTW INVESTMENTS, LP | 13,749,383 | $21,862,000 | 2.04% |
| ARMISTICE CAPITAL, LLC | 4,300,000 | $6,837,000 | 0.52% |
| DAFNA Capital Management LLC | 630,182 | $1,002,000 | 0.50% |
| Rock Springs Capital Management LP | 2,325,000 | $3,697,000 | 0.18% |
| 683 Capital Management, LLC | 1,000,000 | $1,590,000 | 0.10% |
| Alambic Investment Management, L.P. | 133,698 | $213,000 | 0.09% |
| South Dakota Investment Council | 3,037,004 | $7,310,000 | 0.08% |
| Alpine Global Management, LLC | 205,172 | $326,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 402,800 | $640,000 | 0.07% |